The role of small airways in monitoring the response to asthma treatment: What is beyond FEV1?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 11, 2009, Pages 1563-1569

  Scichilone, N ^a   Battaglia, S ^a   Olivieri, D ^b   Bellia, V ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Asthma; Corticosteroids; Lung function; Small airways

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; SALMETEROL;

ASTHMA; CLINICAL TRIAL; DISEASE CONTROL; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPIROMETRY; TRACHEOBRONCHIAL TREE; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; FORCED EXPIRATORY VOLUME; HUMANS; RESPIRATORY FUNCTION TESTS; SPIROMETRY; TREATMENT OUTCOME;

EID: 70349878828     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02139.x     Document Type: Review

References (58)

1. Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P et al. GINA guidelines on asthma and beyond. Allergy 2007 62 : 102 112.
2. Humbert M, Holgate S, Boulet LP, Bousquet J. Asthma control or severity: that is the question. Allergy 2007 62 : 95 101.
3. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004 170 : 836 844.
4. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001 164 : 1392 1397.
5. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006 368 : 744 753.
6. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007 120 : 1360 1367.
7. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006 6 : 13.
8. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000 16 : 802 807.
9. Scichilone N, Marchese R, Soresi S, Interrante A, Togias A, Bellia V. Deep inspiration-induced changes in lung volume decrease with severity of asthma. Respir Med 2007 101 : 951 956.
10. Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001 163 : 924 929.
11. Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Peripheral inflammation in patients with asthmatic symptoms but normal lung function. J Asthma 2005 42 : 605 609.
12. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003 22 : 470 477.
13. Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008 104 : 394 403.
14. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997 100 : 44 51.
15. Tulic MK, Christodoulopoulos P, Hamid Q. Small airway inflammation in asthma. Respir Res 2001 2 : 333 339.
16. Kraft M. The distal airways: are they important in asthma? Eur Respir J 1999 14 : 1403 1417.
17. Carr DH, Hibon S, Rubens M, Chung KF. Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma. Respir Med 1998 92 : 448 453.
18. Newman KB, Lynch DA, Newman LS, Ellegood D, Newell JD Jr. Quantitative computed tomography detects air trapping due to asthma. Chest 1994 106 : 105 109.
19. Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol 1997 7 : 186 192.
20. Balzar S, Wenzel SE, Chu HW. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002 20 : 254 259.
21. Boulet LP. Transbronchial biopsy as a tool to evaluate small-airways disease in asthma. Pros Eur Respir J 2002 20 : 247 248.
22. James A, Carroll N. Transbronchial biopsy as a tool to evaluate small-airways disease in asthma. Cons Eur Respir J 2002 20 : 249 251.
23. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996 154 : 1505 1510.
24. Tashkin DP. The role of small airway inflammation in asthma. Allergy Asthma Proc 2002 23 : 233 242.
25. Yoo Y, Choung JT, Yu J, Kim do K, Choi SH, Koh YY. Comparison of percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV(1) between patients with asymptomatic bronchial hyperresponsiveness and mild asthma. Chest 2007 132 : 106 111.
26. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006 27 : 951 956.
27. Bourdin A, Paganin F, Prefaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy 2006 61 : 85 89.
28. Battaglia S, den Hertog H, Timmers MC, Lazeroms SP, Vignola AM, Rabe KF et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005 60 : 639 644.
29. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993 6 : 1368 1370.
30. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001 163 : 1693 1722.
31. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996 153 : 1510 1514.
32. Jorres RA. Modelling the production of nitric oxide within the human airways. Eur Respir J 2000 16 : 555 560.
33. Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ et al. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans. J Appl Physiol 1999 87 : 1532 1542. (Pubitemid 29483144)
34. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998 85 : 653 666.
35. Jiang J, Malavia N, Suresh V, George SC. Nitric oxide gas phase release in human small airway epithelial cells. Respir Res 2009 10 : 3.
36. Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 2002 20 : 841 845.
37. Mahut B, Delacourt C, Zerah-Lancner F, De Blic J, Harf A, Delclaux C. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004 125 : 1012 1018.
38. Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005 25 : 986 991.
39. Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 2007 102 : 417 425.
40. Kerckx Y, Michils A, Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol 2008 104 : 918 924.
41. Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000 106 : 1209 1226.
42. Lee YM, Park JS, Hwang JH, Park SW, Uh ST, Kim YH et al. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004 126 : 1840 1848.
43. Hauber HP, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003 112 : 58 63.
44. Bergeron C, Hauber HP, Gotfried M, Newman K, Dhanda R, Servi RJ et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2005 116 : 983 989.
45. Thongngarm T, Silkoff PE, Kossack WS, Nelson HS. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma. J Asthma 2005 42 : 257 263.
46. Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone-formoterol vs fluticasone-salmeterol inhaled combination in moderate to severe asthma. Allergy 2007 62 : 1182 1188.
47. Scichilone N, Battaglia S, Sorino C, Paglino G, Martino L, Nicolini G et al. Effects on small airways of two different combination treatments for asthma. Am J Respir Crit Care Med 2009 179 : A5070.
48. Hedenstrom H, Wegener T, Boman G, Wahlander L, Melander B. Effect of inhaled formoterol versus terbutaline on respiratory function in moderate bronchial asthma. Allergy 1992 47 : 158 163.
49. Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006 130 : 1726 1732.
50. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 352 : 2163 2173.
51. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007 176 : 231 237.
52. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008 372 : 1065 1072.
53. Cohen J, Douma WR, ten Hacken NH, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008 31 : 1213 1220.
54. Robroeks CM, van de Kant KD, van Vliet D, Kester AD, Hendriks HJ, Damoiseaux JG et al. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. Ann Allergy Asthma Immunol 2008 100 : 601 607.
55. Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001 18 : 635 639.
56. Gelb AF, Taylor CF, Nussbaum E, Gutierrez C, Schein A, Shinar CM et al. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 2004 170 : 737 741.
57. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002 121 : 1824 1832.
58. Boulet LP. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways? Respir Med 2006 100 : 496 502.